Reply - 07/08/21
Doi : 10.1016/j.jaad.2021.01.091
Qi Chen, MD a, Yan Tang, MD a, Ji Li, MD, PhD a, b, c, d, e, ⁎ 
a Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China
b Key Laboratory of Organ Injury, Aging and Regenerative Medicine of Hunan Province, Central South University, Changsha, Hunan, China
c Key Laboratory of Molecular Radiation Oncology Hunan Province, Changsha, Hunan, China
d National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China
e Department of Dermatology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China
∗Reprint requests: Ji Li, MD, PhD, Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, Hunan, P.R. China 410008Department of DermatologyXiangya HospitalCentral South University87 Xiangya RoadChangshaHunan410008P.R. China
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 85 - N° 3
P. e169 - septembre 2021 Retour au numéro
Article précédent
- Implementing the association between rosacea, hypertension, and dyslipidemia in clinical practice
- Adrian Pona, Jonathan Labbe, Felix Afriyie, Rahim Jiwani, James R. Powell
- Comment on “Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry”
- Hyun-Min Seo, Se Uk Oh, Se Kwang Park, Joung Soo Kim
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?